ACC | GenomeWeb

ACC

NEW YORK (GenomeWeb) — Despite sustained interest among researchers and diagnostics developers in advancing molecular tests to personalize cardiovascular care, integration of such tools into clinical practice is happening slowly where at all.

The company will work with the American College of Cardiology to create a clinical resource on the web for peer-reviewed biomarker information.

Research presented at the American College of Cardiology scientific session in Atlanta today suggests individuals who receive genetic testing early in their warfarin treatment are up to 31 percent less likely to be hospitalized than those who don't.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.